Compass Therapeutics CMPX
NASDAQ CMPX
$1.10 -0.01 (-1.36%)
As of: Sep 29, 2026 · 3:59 PM EDT

Compass Therapeutics (CMPX) Short term Debt (2019 - 2021)

Updated

Compass Therapeutics (CMPX) posted Short term Debt of $3.74 million for Q3 2021.

Analysis

Compass Therapeutics (CMPX) Short term Debt (2019 - 2021) Analysis & Trends

At the end of FY2020, Compass Therapeutics' Short term Debt came in at $7.47 million, up 33.9% from FY2019.

  • In prior years, Compass Therapeutics' Short term Debt was $5.58 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Compass Therapeutics 199.90 Mn 199.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 3.74 Mn
Mar 31, 2021 7.47 Mn
Dec 31, 2020 7.47 Mn
Sep 30, 2020 7.46 Mn
Jun 30, 2020 7.45 Mn
Dec 31, 2019 5.58 Mn
API Access

Compass Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=CMPX&period=max&api_key=YOUR_API_KEY